The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt

Mon, 03rd Jul 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Yourgene Health PLC, more than doubled to 0.47 pence from 0.20p at Friday's market close, 12-month range 0.12p-8.00p. Shares in the medical diagnostics company rocket as it agrees to a takeover offer from Novacyt SA at 0.522 pence per share in cash. The deal values Yourgene's equity at GBP16.7 million. The companies say the acquisition "strongly aligns" with Novacyt's post-Covid strategy, which included pursuing strategic mergers and acquisitions to support its long-term growth and prioritised the twin objectives of geographic expansion and portfolio development. Shares in Novacyt, a fellow AIM listing, jump 24%.

----------

Verici Dx PLC, up 11% at 13.0p, 12-month range 4.53p-19p. The Cardiff, Wales-based developer of clinical diagnostics for organ transplants receives successful results from its clinical study of Clarava that demonstrate it as a test capable of informing a clear, actionable response from clinicians. Clarava is the company's pre-transplant prognostic test to allow measurement of a patient's immune response to assess the risk of early kidney graft rejection, which could assist an estimated 65,000 patients. Verici Dx says it is on track to launch Clarava commercially in the US before the end of 2023.

----------

AIM - LOSERS

----------

Zanaga Iron Ore Co Ltd, down 22% at 9.75p, 12-month range 1.7p-18.9p. The iron explorer focused on the Republic of the Congo enters into an equity subscription agreement with institutional investor Shard Merchant Capital Ltd. Zanaga will issue up to 36 million shares in up to three tranches of 12 million each. At the current price, the shares will be worth GBP3.7 million in total. Also on Monday, Zanaga reports it swung to a pretax profit in 2022 of USD8.1 million from a loss of USD1.9 million the year before. It generated no revenue, unchanged from a year prior, but reports a USD9.1 million gain on the revaluation of investment.

----------

Kibo Energy PLC, down 12% at 0.05p, 12-month range 0.05p-0.22p. The energy projects in Africa and UK says all funding activities, including the company's proposed AIM-listed vehicle Ultimate Sustainable Energy, have been placed on hold due to delays as a result of "difficulties" at its extraordinary general meeting. Early last month, Kibo reported that five of a total of eight resolutions failed to reach the minimum threshold of 75% of the vote at an EGM. These include equity securities allotment, amendment of the Memorandum of Association and amendment of the Articles of Association. It said back then that 35% of shareholders voted against these resolutions. On Thursday last week, Kibo said it sought funding to address a liquidity crunch. It said liquidity constraints resulted from the "significant" capital required to develop its projects.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 Jul 2019 10:07

Yourgene Health Swings To Profit After Debt Write-Off, Strong Trading

(Alliance News) - Yourgene Health PLC on Wednesday posted a swing to profit for its recent financial year due to improved trading and substantial gains on debt restructuring.Shares in were

Read more
3 Jun 2019 16:04

DIRECTOR DEALINGS: Yourgene Health Non-Exec Chair Reynolds Buys Shares

LONDON (Alliance News) - Yourgene Health PLC on Monday said Non-Executive Chair Adam Reynolds bought shares in the diagnostic products developer in a transaction on Friday last purchased 900,000 a

Read more
3 Jun 2019 15:26

Director dealings: Yourgene chairman raises stake

(Sharecast News) - Yourgene Health revealed on Monday that chairman Adam Reynolds had acquired 900,000 ordinary shares in the AIM-listed molecular diagnostics outfit.

Read more
9 May 2019 17:32

DIRECTOR DEALINGS: Yourgene Finance And Operating Chiefs Buy Shares

LONDON (Alliance News) - Yourgene Health PLC said on Thursday that Chief Financial Officer Barry Hextall and Chief Operating Officer Hayden Jeffreys have purchased around GBP35,800 in stock them

Read more
17 Apr 2019 17:29

Yourgene Health Fundraises To Buy Delta Diagnostics For GBP9 Million (ALLISS)

LONDON (Alliance News) - Yourgene Health PLC on Wednesday proposed an acquisition of Delta Diagnostics UK Ltd for an enterprise value of GBP8.8 million.The diagnostic products developer of

Read more
8 Apr 2019 11:37

Yourgene revenues beat estimates on solid international performance

(Sharecast News) - Molecular diagnostics group Yourgene saw annual revenues exceed market expectations in its 2018 trading year, driven by a strong performance from its international arm.

Read more
8 Apr 2019 09:13

International Performance Leads Revenue Rise For Yourgene Health

LONDON (Alliance News) - Yourgene Health PLC on Monday said its annual revenue was ahead of market expectations, with international revenue particularly strong.Shares in molecular company a

Read more
8 Jan 2019 14:22

Yourgene Health launches Sage 32 plex test

(Sharecast News) - Molecular diagnostics group Yourgene Health announced the launch of the 'Sage 32' plex test - a high throughput non-invasive prenatal testing (NIPT) and analysis solution for clinical laboratories - on Tuesday.

Read more
8 Jan 2019 10:07

Yourgene Health Launches Sage 32 Plex Test For Clinical Laboratories

LONDON (Alliance News) - Yourgene Health PLC on Tuesday said it launched the Sage 32 plex test, a new high-throughput, non-invasive prenatal testing and analysis solution for clinical molecular 32

Read more
3 Dec 2018 12:01

Yourgene Health Interim Loss Narrows On Double-Digit Revenue Growth

LONDON (Alliance News) - Yourgene Health PLC on Monday said its loss narrowed in the first half of its current financial year as revenue rose on improved non-invasive prenatal testing products its

Read more
3 Dec 2018 10:27

Yourgene Health international expansion sees revenue jump 45%

(Sharecast News) - Yourgene Health's shares dropped on Monday as the company returned a loss even after interim revenue increased by almost 50%.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.